Introduction
Program
Speakers
Sponsor list
Accreditation

AOP 2023
Program

FOCUS ON S043

Anti-VEGF in retinal pathology

Room: Amphi Havane
Date: Saturday 4 February 2023 at 08:30 to 09:30
Format: FOCUS SESSION > lectures covering a major topic of the congress

Chair

Dr Christine FARDEAU

Ophthalmologist

France

Lectures of the workshop

Hours	Speakers	Lecture title	Abstract	Number
08:30	Dr Christine FARDEAU	Anti VEGF IVT during uveitis		116586
08:45	Dr Agnes GLACET BERNARD	Anti VEGF IVT during RVO		121771
09:00	Dr Alexandra MIERE	Anti VEGF IVT during DMLA		121869
09:15		Questions and answers		116381

Go to previous day (Room 353)

Go to next session

Dr Christine FARDEAU

Ophthalmologist

France

Other author(s) :

Anti VEGF IVT during uveitis

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Agnes GLACET BERNARD

Ophthalmologist

France

Other author(s) :

Anti VEGF IVT during RVO

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Alexandra MIERE

Ophthalmologist

France

Other author(s) :

Anti VEGF IVT during DMLA

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

AOP 2023 Program

FOCUS ON S043

Anti-VEGF in retinal pathology

Chair

Lectures of the workshop

AOP 2023
Program